Science & health
UK review calls for continuous oversight of AI used in healthcare
The UK's medicines and devices regulator has published 44 recommendations for updating oversight of AI in healthcare. They include ongoing monitoring, clearer patient information, penalties for failures and closely supervised trials for new systems. The central concern is that an AI product can change after authorization as data and behavior shift. These are recommendations emerging from an independent commission, not a declaration that new laws are already in force or that AI can replace clinical judgment.
Editorial summary · Publisher article
What matters
- The commission received input from more than 12,000 people, including patients and clinicians.
- The regulator argues that rules designed for conventional medical devices do not fully address changing AI systems.
Why this made the edition
Substantive evidence supports this distinct development; selected for reader relevance and importance after comparison with published history.
Source material